Associate Professor Judy Kirk

Clinical Associate Professor
Medicine, Westmead Clinical School
Westmead Millennium Institute for Medical Research

Telephone 9845 6947
Fax 9845 9217

Map

Selected grants

2012

  • The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (KconFab - a national and international resource for research into familial breast cancer); Fox S, Kirk J; National Breast Cancer Foundation/Infrastructure Grant.

2010

  • Randomised trial of consumer-led familiar cancer risk tool & GP triage on risk-appropriate colorectal cancer screening; Trevena L, Meiser B, Meiser B, Kirk J, Barlow-Stewart K, Dobbins T, Goodwin A; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2003

  • kConFab: A National Consortium for Research into Familial Breast Cancer.; Kirk J; Cancer Council New South Wales/Research Project Grants.

2002

  • A national consortium for research into familial breast cancer; Kirk J; Cancer Council New South Wales/Research Project Grants.

2000

  • Early events predisposing to breast cancer in women with a genetic susceptibility; Clarke C, Leary J, Balleine R, Kirk J; Leo and Jenny Leukaemia and Cancer Foundation/Leukaemia and Cancer Foundation.
  • Transgenomic WAVE 2100 denaturing HPLC system for DNA variant analysis; Farrell G, Clarke C, Cunningham A, deFazio A, Kirk J, Leary J, Liddle C, Manolios N, Mitchell P, Stewart G, Mann G; National Health and Medical Research Council (NHMRC)/Equipment Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Kirk, J. (2010). Genetic Testing for Cancer Susceptibility: How and When? In Monica Robotin, Ian Olver, Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physicians Handbook, (pp. 931-939). London: Imperial College Press.
  • Hallett, K., Cameron, A., Widmer, R., King, P., Kilpatrick, N., Wilson, M., Lucas, J., Wong, P., Mekertichian, K., Isaacs, D., Kirk, J., et al (2003). Medically compromised children. In Cameron, Widmer (Eds.), Handbook of Pediatric Dentistry, Second Editions, (pp. 234-286). Australia: Mosby.

Journals

  • Dunlop, K., Kirk, J., Tucker, K. (2014). In the wake of Angelina - Managing a family history of breast cancer. Australian Family Physician, 43(1-2), 76-78.
  • McBride, K., Ballinger, M., Killick, E., Kirk, J., Tattersall, M., Eeles, R., Thomas, D., Mitchell, G. (2014). Li-Fraumeni syndrome: cancer risk assessment and clinical management. Nature Reviews Clinical Oncology, 11(5), 260-271. [More Information]
  • Wickremeratne, T., Lee, C., Kirk, J., Charlton, A., Thomas, G., Gaskin, K. (2014). Prophylactic gastrectomy in a 16-year-old. European Journal of Gastroenterology and Hepatology, 26(3), 353-356. [More Information]
  • Buchanan, D., Tan, Y., Walsh, M., Clendenning, M., Metcalf, A., Ferguson, K., Arnold, S., Thompson, B., Lose, F., Parsons, M., Kirk, J., et al (2014). Tumor Mismatch Repair Immunohistochemistry and DNA MLH1 Methylation Testing of Patients With Endometrial Cancer Diagnosed at Age Younger Than 60 Years Optimizes Triage for Population-Level Germline Mismatch Repair Gene Mutation Testing. Journal of Clinical Oncology, 32(2), 90-100. [More Information]
  • Garcia-Closas, M., Couch, F., Lindstrom, S., Michailidou, K., Schmidt, M., Brook, M., Orr, N., Rhie, S., Riboli, E., Feigelson, H., Carpenter, J., Balleine, R., et al (2013). Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature Genetics, 45(4), 392-398. [More Information]
  • Wakefield, C., Thorne, H., Kirk, J., Niedermayr, E., Doolan, E., Tucker, K. (2013). Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancer. Genetics in Medicine, 15(3), 187-194. [More Information]
  • Burcher, S., Meiser, B., Mitchell, G., Saunders, C., Rahman, B., Tucker, K., Barlow-Stewart, K., Watts, K., Gleeson, M., Kirk, J. (2013). Oncology health professionals attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer. Personalized Medicine, 10(5), 431-440. [More Information]
  • Antoniou, A., Kuchenbaecker, K., Soucy, P., Beesley, J., Chen, X., McGuffog, L., Lee, A., Barrowdale, D., Healey, S., Sinilnikova, O., Kirk, J., et al (2012). Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research, 14(1), 1-18. [More Information]
  • Meiser, B., Gleeson, M., Watts, K., Peate, M., Zilliacus, E., Barlow-Stewart, K., Saunders, C., Mitchell, G., Kirk, J. (2012). Getting to the Point: What Women Newly Diagnosed with Breast Cancer Want to Know About Treatment-Focused Genetic Testing. Oncology Nursing Forum, 39(2), E101-E111. [More Information]
  • Watts, K., Meiser, B., Mitchell, G., Kirk, J., Saunders, C., Peate, M., Duffy, J., Kelly, P., Gleeson, M., Barlow-Stewart, K., et al (2012). How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer. BMC Cancer, 12(1), 1-12. [More Information]
  • Saleh, M., Barlow-Stewart, K., Meiser, B., Tucker, K., Eisenbruch, M., Kirk, J. (2012). Knowledge, attitudes and beliefs of Arabic-Australians concerning cancer. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 21(2), 195-202. [More Information]
  • Saleh, M., Barlow-Stewart, K., Meiser, B., Kirk, J., Tucker, K. (2011). An Exploration of the Cultural Context of Kinship and Genetics Amongst Arabic-Australians: Implications for Practice. Journal of Genetic Counseling, 20(5), 465-475. [More Information]
  • Zilliacus, E., Meiser, B., Lobb, E., Kelly, P., Barlow-Stewart, K., Kirk, J., Spigelman, A., Warwick, L., Tucker, K. (2011). Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling? Genetics in Medicine, 13(11), 933-941. [More Information]
  • Mitra, A., Bancroft, E., Barbachano, Y., Page, E., Foster, C., Jameson, C., Mitchell, G., Lindeman, G., Stapleton, A., Suthers, G., Kirk, J., et al (2011). Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU International, 107(1), 28-39. [More Information]
  • Antill, Y., Mitchell, G., Johnson, S., Devereux, L., Milner, A., Di Iulio, J., Lindeman, G., Kirk, J., Phillips, K., Campbell, I. (2010). Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology, Biomarkers and Prevention, 19(1), 265-274. [More Information]
  • Whitaker, H., Kote-Jarai, Z., Ross-Adams, H., Warren, A., Burge, J., George, A., Bancroft, E., Jhavar, S., Leongamornlert, D., Tymrakiewicz, M., Kirk, J., et al (2010). The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PloS One, 5(10), e13363. [More Information]
  • Zilliacus, E., Meiser, B., Lobb, E., Kirk, J., Warwick, L., Tucker, K. (2010). Women's Experience of Telehealth Cancer Genetic Counseling. Journal of Genetic Counseling, 19(5), 463-472. [More Information]
  • Shanley, S., Fung, C., Milliken, J., Leary, J., Barnetson, R., Schnitzler, M., Kirk, J. (2009). Breast cancer immunohistochemistry can be useful in triage of some HNPCC families. Familial Cancer, 8, 251-255. [More Information]
  • Juan, A., Wakefield, C., Kasparian, N., Kirk, J., Tyler, J., Tucker, K. (2008). Development and Pilot Testing of a Decision Aid for Men Considering Genetic Testing for Breast and/or Ovarian Cancer-Related Mutations (BRCA1/2). Genetic Testing, 12, 523-532. [More Information]
  • Wakefield, C., Meiser, B., Homewood, J., Ward, R., O'Donnell, S., Kirk, J. (2008). Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk. Cancer, 113, 956-965. [More Information]
  • Wakefield, C., Meiser, B., Homewood, J., Peate, M., Taylor, A., Lobb, E., Kirk, J., Young, M., Williams, R., Dudding, T., et al (2007). A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Research and Treatment, 107(2), 289-301. [More Information]
  • Wakefield, C., Kasparian, N., Meiser, B., Homewood, J., Kirk, J., Tucker, K. (2007). Attitudes Toward Genetic Testing for Cancer Risk after Genetic Counseling and Decision Support: A Qualitative Comparison between Hereditary Cancer Types. Genetic Testing, 11(4), 401-412. [More Information]
  • Wakefield, C., Meiser, B., Homewood, J., Peate, M., Kirk, J., Warner, B., Lobb, E., Gaff, C., Tucker, K. (2007). Development and pilot testing of two decision Aids for individuals considering genetic testing for cancer risk. Journal of Genetic Counseling, 16(3), 325-339. [More Information]
  • Featherstone, C., Colley, A., Tucker, K., Kirk, J., Barton, M. (2007). Estimating the referral rate for cancer genetic assessment from a systematic review of the evidence. British Journal of Cancer, 96(2), 391-398.
  • Field, M., Shanley, S., Kirk, J. (2007). Inherited cancer susceptibility syndromes in paediatric practice. Journal of Paediatrics and Child Health, 43(4), 219-229. [More Information]
  • Kirk, J., Suthers, G. (2007). Overview. Cancer Forum, 31(3), 135-138.
  • Kirk, J. (2007). The role of familial Cancer Services. Cancer Forum, 31(3), 136-138.
  • Tiller, K., Meiser, B., Gaff, C., Kirk, J., Dudding, T., Phillips, K., Friedlander, M., Tucker, K. (2006). A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer. Medical Decision Making: an international journal, 26(4), 360-372. [More Information]
  • Kirk, J., Brennan, M., Houssami, N., Ung, O. (2006). An approach to the patient with a family history of breast cancer. Australian Family Physician, 35(1-2), 43-47. [More Information]
  • Mann, G., Thorne, H., Balleine, R., Butow, P., Clarke, C., Edkins, E., Evans, G., Fereday, S., Haan, E., Gattas, M., Kirk, J., Leary, J., Pupo, G., et al (2006). Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Research, 8(1), 1-15. [More Information]
  • Lobb, E., Butow, P., Moore, A., Barratt, A., Tucker, K., Gaff, C., Kirk, J., Dudding, T., Butt, D. (2006). Development of a communication aid to facilitate risk communication in consultations with unaffected women from high risk breast cancer families: A pilot study. Journal of Genetic Counseling, 15(5), 393-405. [More Information]
  • Kang, H., Williams, R., Leary, J., Ringland, C., Kirk, J., Ward, R. (2006). Evaluation of models to predict BRCA germline mutations. British Journal of Cancer, 95(7), 914-920. [More Information]
  • Balleine, R., Murali, R., Bilous, M., Farshid, G., Waring, P., Provan, P., Byth Wilson, K., Thorne, H., KConFab, C., Kirk, J. (2006). Histopathological features of breast cancer in carriers of ATM gene variants. Histopathology, 49. [More Information]
  • Kirk, J. (2006). How can we best detect hereditary non-polyposis colorectal cancer? Medical Journal of Australia, 184(5), 206-207.
  • Antill, Y., Reynolds, J., Young, M., Kirk, J., Tucker, K., Bogtstra, T., Wong, S., Dudding, T., Di Iulio, J., Phillips, K. (2006). Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer. European Journal of Cancer, 42(5), 621-628. [More Information]
  • Antill, Y., Reynolds, J., Young, M., Kirk, J., Tucker, K., Bogtstra, T., Wong, S., Dudding, T., Di Iulio, J., Phillips, K. (2006). Screening behavior in women at increased familial risk for breast cancer. Familial Cancer, 5(4), 359-368. [More Information]
  • Kirk, J. (2006). Who needs Cancer screening. ANZ Journal of Surgery, 76(Supp1), A78.
  • Brennan, M., French, J., Houssami, N., Kirk, J., Boyages, J. (2005). Breast cancer in young women. Australian Family Physician, 34(10), 851-855. [More Information]
  • Woodward, A., Davis, T., Silva, A., KConFab, C., Kirk, J., Leary, J. (2005). Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. Journal of Medical Genetics, 42(5), e31-e34. [More Information]
  • Hitchins, M., Williams, R., Cheong, K., Halani, N., Lin, V., Packham, D., Ku, S., Buckle, A., Hawkins, N., Kirk, J., et al (2005). MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology, 129. [More Information]
  • Kairupan, C., Meldrum, C., Crooks, R., Milward, E., Spigelman, A., Burgess, B., Groombridge, C., Kirk, J., Tucker, K., Ward, R., et al (2005). Mutation analysis of the MYH gene in an Australian series of colorectal polyposis patients with or without germline APC mutations. International Journal of Cancer, 116(1), 73-77. [More Information]
  • Mitchell, G., Antill, Y., Murray, W., Kirk, J., Salisbury, E., Lindeman, G., Di Iulio, J., Milner, A., Devereaux, L., Phillips, K. (2005). Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation. Breast Cancer Research, 7(6), R1122-R1131. [More Information]
  • Weir, L., Spigelman, A., Scott, R., Kirk, J., Zeckendorf, S., Sitas, F. (2005). The NSW & ACT Hereditary Cancer Registers. Australian Family Physician, 34(1-2), 53-58. [More Information]
  • Lindeman, G., Hiew, M., Visvader, J., Leary, J., Field, M., Gaff, C., McKinlay Garnder, R., Trainor, K., Cheetham, G., Suthers, G., Kirk, J. (2004). Frequency Of The Atm Ivs10-6T-->G Variant In Australian Multiple-Case Breast Cancer Families. Breast Cancer Research, 6(4), R401-7.
  • Mote, P., Leary, J., Avery, K., Sandelin, K., Chenevix-Trench, G., kConFab Investigators., Kirk, J., Clarke, C. (2004). Germ-Line Mutations In Brca1 Or Brca2 In The Normal Breast Are Associated With Altered Expression Of Estrogen-Responsive Proteins And The Predominance Of Progesterone Receptor A. Genes Chromosomes and Cancer, 39(3), 236-248. [More Information]
  • Kirk, J. (2004). Letter: Gene silencing. New England Journal of Medicine, 350(9), 947-948.
  • Kirk, J. (2004). Letter: Genetic testing: a round table conversation. Internal Medicine Journal, 34(7), 445.
  • Kirk, J. (2004). The family history of cancer - a common concern in palliative care. Progress in Palliative Care, 12(2), 59-66.
  • Keogh, L., Southey, M., Maskiell, J., Young, M., Gaff, C., Kirk, J., Tucker, K., Rosenthal, D., McCredie, M., Giles, G., et al (2004). Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study. Cancer Epidemiology, Biomarkers and Prevention, 13(12), 2258-2263.
  • Tiller, K., Meiser, B., Reeson, E., Tucker, M., Andrews, L., Gaff, C., Kirk, J., Phillips, K., Friedlander, M. (2003). A decision aid for women at increased risk for ovarian cancer. International Journal Of Gynecological Cancer, 13(1), 15-22.
  • Fisher, T., Kirk, J., Hopper, J., Godding, R., Burgemeister, F. (2003). A simple tool for identifying unaffected women at a moderately increased or potentially high risk of breast cancer based on their family history. The Breast, 12(2), 120-127.
  • Kirk, J. (2003). How to treat familial cancer. Australian Doctor, , 25-32.
  • Shannon, C., Kirk, J., Barnetson, R., Evans, J., Schnitzler, M., Quinn, M., Hacker, N., Crandon, A., Harnett, P. (2003). Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium. Clinical Cancer Research, 9(4), 1387-1392.
  • Lobb, E., Butow, P., Meiser, B., Barratt, A., Gaff, C., Young, M., Kirk, J., Gattans, M., Gleeson, M., Tucker, K. (2003). Women's preferences and consultants' communication of risk in consultations about familial breast cancer: impact on patient outcomes. Journal of Medical Genetics, 40(5 - e56), 1-8.
  • Chenevix-Trench, G., Spurdle, A., Gatei, M., Kelly, H., Marsh, A., Chen, X., Donn, K., Cummings, M., Nyholt, D., Jenkins, M., Pupo, G., Kirk, J., Tucker, P., Mann, G., et al (2002). Dominant Negative ATM Mutations in Breast Cancer Families. Journal of the National Cancer Institute, 94(3), 205-215.
  • Lobb, E., Butow, P., Meiser, B., Barratt, A., Gaff, C., Young, M., Kirk, J., Suthers, G., Tucker, K. (2002). Tailoring communication in consultations with women from high risk breast cancer families. British Journal of Cancer, 87(5), 502-508.
  • Lobb, E., Butow, P., Meiser, B., Barratt, A., Kirk, J., Gattas, M., Haan, E., Tucker, K. (2002). The use of audiotapes in consultations with women from high risk breast cancer families: a randomised trial. Journal of Medical Genetics, 39(9), 697-703.
  • Scott, R., Meldrum, C., Crooks, R., Spigelman, A., Kirk, J., Tucker, K., Koorey, D., Hunter, F. (2001). Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity. Gut (English Edition): an international journal of gastroenterology and hepatology, 48(4), 508-514.
  • Scott, R., McPhillips, M., Meldrum, C., FitzGerald, P., Adams, K., Spigelman, A., du Sart, D., Tucker, K., Kirk, J. (2001). Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. American Journal of Human Genetics, 68(1), 118-127.
  • Randall, J., Butow, P., Kirk, J., Tucker, K. (2001). Psychological impact of genetic counselling and testing in women previously diagnosed with breast cancer. Internal Medicine Journal, 31(7), 397-405.
  • Meiser, B., Butow, P., Barratt, A., Friedlander, M., Kirk, J., Gaff, C., Haan, E., Aittomaki, K., Tucker, K. (2000). Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. Breast Cancer Research and Treatment, 59(2), 101-111.
  • Kirk, J., Kefford, R. (2000). Cancer in the family: risks and management. Medical Journal of Australia, 172(11), 529-530.
  • Meiser, B., Butow, P., Friedlander, M., Schnieden, V., Gattas, M., Kirk, J., Suthers, G., Haan, E., Tucker, K. (2000). Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. Journal of Clinical Oncology, 18(11), 2250-2257.
  • Osborne, R., Hopper, J., Kirk, J., Chenevix-Trench, G., Thorne, H., Sambrook, J. (2000). kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Medical Journal of Australia, 172(9), 463-464.

Magazine / Newspaper Articles

  • Jenkins, M., Macrae, F., Young, J., Barker, M., Leggett, B., Goldblatt, J., Kirk, J., Tucker, K., Suthers, G., Young, G., et al (2006). The Colorectal Cancer Family Registry: An international resource for studying the genetic and molecular epidemiology of colorectal cancer. Gastrointestinal Cancer Update Vol. 46.
  • Kirk, J. (2001). Explaining the familial aspects of breast cancer. The Beacon (Breast Cancer Network Australia).

2014

  • Dunlop, K., Kirk, J., Tucker, K. (2014). In the wake of Angelina - Managing a family history of breast cancer. Australian Family Physician, 43(1-2), 76-78.
  • McBride, K., Ballinger, M., Killick, E., Kirk, J., Tattersall, M., Eeles, R., Thomas, D., Mitchell, G. (2014). Li-Fraumeni syndrome: cancer risk assessment and clinical management. Nature Reviews Clinical Oncology, 11(5), 260-271. [More Information]
  • Wickremeratne, T., Lee, C., Kirk, J., Charlton, A., Thomas, G., Gaskin, K. (2014). Prophylactic gastrectomy in a 16-year-old. European Journal of Gastroenterology and Hepatology, 26(3), 353-356. [More Information]
  • Buchanan, D., Tan, Y., Walsh, M., Clendenning, M., Metcalf, A., Ferguson, K., Arnold, S., Thompson, B., Lose, F., Parsons, M., Kirk, J., et al (2014). Tumor Mismatch Repair Immunohistochemistry and DNA MLH1 Methylation Testing of Patients With Endometrial Cancer Diagnosed at Age Younger Than 60 Years Optimizes Triage for Population-Level Germline Mismatch Repair Gene Mutation Testing. Journal of Clinical Oncology, 32(2), 90-100. [More Information]

2013

  • Garcia-Closas, M., Couch, F., Lindstrom, S., Michailidou, K., Schmidt, M., Brook, M., Orr, N., Rhie, S., Riboli, E., Feigelson, H., Carpenter, J., Balleine, R., et al (2013). Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature Genetics, 45(4), 392-398. [More Information]
  • Wakefield, C., Thorne, H., Kirk, J., Niedermayr, E., Doolan, E., Tucker, K. (2013). Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancer. Genetics in Medicine, 15(3), 187-194. [More Information]
  • Burcher, S., Meiser, B., Mitchell, G., Saunders, C., Rahman, B., Tucker, K., Barlow-Stewart, K., Watts, K., Gleeson, M., Kirk, J. (2013). Oncology health professionals attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer. Personalized Medicine, 10(5), 431-440. [More Information]

2012

  • Antoniou, A., Kuchenbaecker, K., Soucy, P., Beesley, J., Chen, X., McGuffog, L., Lee, A., Barrowdale, D., Healey, S., Sinilnikova, O., Kirk, J., et al (2012). Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research, 14(1), 1-18. [More Information]
  • Meiser, B., Gleeson, M., Watts, K., Peate, M., Zilliacus, E., Barlow-Stewart, K., Saunders, C., Mitchell, G., Kirk, J. (2012). Getting to the Point: What Women Newly Diagnosed with Breast Cancer Want to Know About Treatment-Focused Genetic Testing. Oncology Nursing Forum, 39(2), E101-E111. [More Information]
  • Watts, K., Meiser, B., Mitchell, G., Kirk, J., Saunders, C., Peate, M., Duffy, J., Kelly, P., Gleeson, M., Barlow-Stewart, K., et al (2012). How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer. BMC Cancer, 12(1), 1-12. [More Information]
  • Saleh, M., Barlow-Stewart, K., Meiser, B., Tucker, K., Eisenbruch, M., Kirk, J. (2012). Knowledge, attitudes and beliefs of Arabic-Australians concerning cancer. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 21(2), 195-202. [More Information]

2011

  • Saleh, M., Barlow-Stewart, K., Meiser, B., Kirk, J., Tucker, K. (2011). An Exploration of the Cultural Context of Kinship and Genetics Amongst Arabic-Australians: Implications for Practice. Journal of Genetic Counseling, 20(5), 465-475. [More Information]
  • Zilliacus, E., Meiser, B., Lobb, E., Kelly, P., Barlow-Stewart, K., Kirk, J., Spigelman, A., Warwick, L., Tucker, K. (2011). Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling? Genetics in Medicine, 13(11), 933-941. [More Information]
  • Mitra, A., Bancroft, E., Barbachano, Y., Page, E., Foster, C., Jameson, C., Mitchell, G., Lindeman, G., Stapleton, A., Suthers, G., Kirk, J., et al (2011). Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU International, 107(1), 28-39. [More Information]

2010

  • Antill, Y., Mitchell, G., Johnson, S., Devereux, L., Milner, A., Di Iulio, J., Lindeman, G., Kirk, J., Phillips, K., Campbell, I. (2010). Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology, Biomarkers and Prevention, 19(1), 265-274. [More Information]
  • Kirk, J. (2010). Genetic Testing for Cancer Susceptibility: How and When? In Monica Robotin, Ian Olver, Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physicians Handbook, (pp. 931-939). London: Imperial College Press.
  • Whitaker, H., Kote-Jarai, Z., Ross-Adams, H., Warren, A., Burge, J., George, A., Bancroft, E., Jhavar, S., Leongamornlert, D., Tymrakiewicz, M., Kirk, J., et al (2010). The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PloS One, 5(10), e13363. [More Information]
  • Zilliacus, E., Meiser, B., Lobb, E., Kirk, J., Warwick, L., Tucker, K. (2010). Women's Experience of Telehealth Cancer Genetic Counseling. Journal of Genetic Counseling, 19(5), 463-472. [More Information]

2009

  • Shanley, S., Fung, C., Milliken, J., Leary, J., Barnetson, R., Schnitzler, M., Kirk, J. (2009). Breast cancer immunohistochemistry can be useful in triage of some HNPCC families. Familial Cancer, 8, 251-255. [More Information]

2008

  • Juan, A., Wakefield, C., Kasparian, N., Kirk, J., Tyler, J., Tucker, K. (2008). Development and Pilot Testing of a Decision Aid for Men Considering Genetic Testing for Breast and/or Ovarian Cancer-Related Mutations (BRCA1/2). Genetic Testing, 12, 523-532. [More Information]
  • Wakefield, C., Meiser, B., Homewood, J., Ward, R., O'Donnell, S., Kirk, J. (2008). Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk. Cancer, 113, 956-965. [More Information]

2007

  • Wakefield, C., Meiser, B., Homewood, J., Peate, M., Taylor, A., Lobb, E., Kirk, J., Young, M., Williams, R., Dudding, T., et al (2007). A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Research and Treatment, 107(2), 289-301. [More Information]
  • Wakefield, C., Kasparian, N., Meiser, B., Homewood, J., Kirk, J., Tucker, K. (2007). Attitudes Toward Genetic Testing for Cancer Risk after Genetic Counseling and Decision Support: A Qualitative Comparison between Hereditary Cancer Types. Genetic Testing, 11(4), 401-412. [More Information]
  • Wakefield, C., Meiser, B., Homewood, J., Peate, M., Kirk, J., Warner, B., Lobb, E., Gaff, C., Tucker, K. (2007). Development and pilot testing of two decision Aids for individuals considering genetic testing for cancer risk. Journal of Genetic Counseling, 16(3), 325-339. [More Information]
  • Featherstone, C., Colley, A., Tucker, K., Kirk, J., Barton, M. (2007). Estimating the referral rate for cancer genetic assessment from a systematic review of the evidence. British Journal of Cancer, 96(2), 391-398.
  • Field, M., Shanley, S., Kirk, J. (2007). Inherited cancer susceptibility syndromes in paediatric practice. Journal of Paediatrics and Child Health, 43(4), 219-229. [More Information]
  • Kirk, J., Suthers, G. (2007). Overview. Cancer Forum, 31(3), 135-138.
  • Kirk, J. (2007). The role of familial Cancer Services. Cancer Forum, 31(3), 136-138.

2006

  • Tiller, K., Meiser, B., Gaff, C., Kirk, J., Dudding, T., Phillips, K., Friedlander, M., Tucker, K. (2006). A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer. Medical Decision Making: an international journal, 26(4), 360-372. [More Information]
  • Kirk, J., Brennan, M., Houssami, N., Ung, O. (2006). An approach to the patient with a family history of breast cancer. Australian Family Physician, 35(1-2), 43-47. [More Information]
  • Mann, G., Thorne, H., Balleine, R., Butow, P., Clarke, C., Edkins, E., Evans, G., Fereday, S., Haan, E., Gattas, M., Kirk, J., Leary, J., Pupo, G., et al (2006). Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Research, 8(1), 1-15. [More Information]
  • Lobb, E., Butow, P., Moore, A., Barratt, A., Tucker, K., Gaff, C., Kirk, J., Dudding, T., Butt, D. (2006). Development of a communication aid to facilitate risk communication in consultations with unaffected women from high risk breast cancer families: A pilot study. Journal of Genetic Counseling, 15(5), 393-405. [More Information]
  • Kang, H., Williams, R., Leary, J., Ringland, C., Kirk, J., Ward, R. (2006). Evaluation of models to predict BRCA germline mutations. British Journal of Cancer, 95(7), 914-920. [More Information]
  • Balleine, R., Murali, R., Bilous, M., Farshid, G., Waring, P., Provan, P., Byth Wilson, K., Thorne, H., KConFab, C., Kirk, J. (2006). Histopathological features of breast cancer in carriers of ATM gene variants. Histopathology, 49. [More Information]
  • Kirk, J. (2006). How can we best detect hereditary non-polyposis colorectal cancer? Medical Journal of Australia, 184(5), 206-207.
  • Antill, Y., Reynolds, J., Young, M., Kirk, J., Tucker, K., Bogtstra, T., Wong, S., Dudding, T., Di Iulio, J., Phillips, K. (2006). Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer. European Journal of Cancer, 42(5), 621-628. [More Information]
  • Antill, Y., Reynolds, J., Young, M., Kirk, J., Tucker, K., Bogtstra, T., Wong, S., Dudding, T., Di Iulio, J., Phillips, K. (2006). Screening behavior in women at increased familial risk for breast cancer. Familial Cancer, 5(4), 359-368. [More Information]
  • Jenkins, M., Macrae, F., Young, J., Barker, M., Leggett, B., Goldblatt, J., Kirk, J., Tucker, K., Suthers, G., Young, G., et al (2006). The Colorectal Cancer Family Registry: An international resource for studying the genetic and molecular epidemiology of colorectal cancer. Gastrointestinal Cancer Update Vol. 46.
  • Kirk, J. (2006). Who needs Cancer screening. ANZ Journal of Surgery, 76(Supp1), A78.

2005

  • Brennan, M., French, J., Houssami, N., Kirk, J., Boyages, J. (2005). Breast cancer in young women. Australian Family Physician, 34(10), 851-855. [More Information]
  • Woodward, A., Davis, T., Silva, A., KConFab, C., Kirk, J., Leary, J. (2005). Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. Journal of Medical Genetics, 42(5), e31-e34. [More Information]
  • Hitchins, M., Williams, R., Cheong, K., Halani, N., Lin, V., Packham, D., Ku, S., Buckle, A., Hawkins, N., Kirk, J., et al (2005). MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology, 129. [More Information]
  • Kairupan, C., Meldrum, C., Crooks, R., Milward, E., Spigelman, A., Burgess, B., Groombridge, C., Kirk, J., Tucker, K., Ward, R., et al (2005). Mutation analysis of the MYH gene in an Australian series of colorectal polyposis patients with or without germline APC mutations. International Journal of Cancer, 116(1), 73-77. [More Information]
  • Mitchell, G., Antill, Y., Murray, W., Kirk, J., Salisbury, E., Lindeman, G., Di Iulio, J., Milner, A., Devereaux, L., Phillips, K. (2005). Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation. Breast Cancer Research, 7(6), R1122-R1131. [More Information]
  • Weir, L., Spigelman, A., Scott, R., Kirk, J., Zeckendorf, S., Sitas, F. (2005). The NSW & ACT Hereditary Cancer Registers. Australian Family Physician, 34(1-2), 53-58. [More Information]

2004

  • Lindeman, G., Hiew, M., Visvader, J., Leary, J., Field, M., Gaff, C., McKinlay Garnder, R., Trainor, K., Cheetham, G., Suthers, G., Kirk, J. (2004). Frequency Of The Atm Ivs10-6T-->G Variant In Australian Multiple-Case Breast Cancer Families. Breast Cancer Research, 6(4), R401-7.
  • Mote, P., Leary, J., Avery, K., Sandelin, K., Chenevix-Trench, G., kConFab Investigators., Kirk, J., Clarke, C. (2004). Germ-Line Mutations In Brca1 Or Brca2 In The Normal Breast Are Associated With Altered Expression Of Estrogen-Responsive Proteins And The Predominance Of Progesterone Receptor A. Genes Chromosomes and Cancer, 39(3), 236-248. [More Information]
  • Kirk, J. (2004). Letter: Gene silencing. New England Journal of Medicine, 350(9), 947-948.
  • Kirk, J. (2004). Letter: Genetic testing: a round table conversation. Internal Medicine Journal, 34(7), 445.
  • Kirk, J. (2004). The family history of cancer - a common concern in palliative care. Progress in Palliative Care, 12(2), 59-66.
  • Keogh, L., Southey, M., Maskiell, J., Young, M., Gaff, C., Kirk, J., Tucker, K., Rosenthal, D., McCredie, M., Giles, G., et al (2004). Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study. Cancer Epidemiology, Biomarkers and Prevention, 13(12), 2258-2263.

2003

  • Tiller, K., Meiser, B., Reeson, E., Tucker, M., Andrews, L., Gaff, C., Kirk, J., Phillips, K., Friedlander, M. (2003). A decision aid for women at increased risk for ovarian cancer. International Journal Of Gynecological Cancer, 13(1), 15-22.
  • Fisher, T., Kirk, J., Hopper, J., Godding, R., Burgemeister, F. (2003). A simple tool for identifying unaffected women at a moderately increased or potentially high risk of breast cancer based on their family history. The Breast, 12(2), 120-127.
  • Kirk, J. (2003). How to treat familial cancer. Australian Doctor, , 25-32.
  • Shannon, C., Kirk, J., Barnetson, R., Evans, J., Schnitzler, M., Quinn, M., Hacker, N., Crandon, A., Harnett, P. (2003). Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium. Clinical Cancer Research, 9(4), 1387-1392.
  • Hallett, K., Cameron, A., Widmer, R., King, P., Kilpatrick, N., Wilson, M., Lucas, J., Wong, P., Mekertichian, K., Isaacs, D., Kirk, J., et al (2003). Medically compromised children. In Cameron, Widmer (Eds.), Handbook of Pediatric Dentistry, Second Editions, (pp. 234-286). Australia: Mosby.
  • Lobb, E., Butow, P., Meiser, B., Barratt, A., Gaff, C., Young, M., Kirk, J., Gattans, M., Gleeson, M., Tucker, K. (2003). Women's preferences and consultants' communication of risk in consultations about familial breast cancer: impact on patient outcomes. Journal of Medical Genetics, 40(5 - e56), 1-8.

2002

  • Chenevix-Trench, G., Spurdle, A., Gatei, M., Kelly, H., Marsh, A., Chen, X., Donn, K., Cummings, M., Nyholt, D., Jenkins, M., Pupo, G., Kirk, J., Tucker, P., Mann, G., et al (2002). Dominant Negative ATM Mutations in Breast Cancer Families. Journal of the National Cancer Institute, 94(3), 205-215.
  • Lobb, E., Butow, P., Meiser, B., Barratt, A., Gaff, C., Young, M., Kirk, J., Suthers, G., Tucker, K. (2002). Tailoring communication in consultations with women from high risk breast cancer families. British Journal of Cancer, 87(5), 502-508.
  • Lobb, E., Butow, P., Meiser, B., Barratt, A., Kirk, J., Gattas, M., Haan, E., Tucker, K. (2002). The use of audiotapes in consultations with women from high risk breast cancer families: a randomised trial. Journal of Medical Genetics, 39(9), 697-703.

2001

  • Kirk, J. (2001). Explaining the familial aspects of breast cancer. The Beacon (Breast Cancer Network Australia).
  • Scott, R., Meldrum, C., Crooks, R., Spigelman, A., Kirk, J., Tucker, K., Koorey, D., Hunter, F. (2001). Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity. Gut (English Edition): an international journal of gastroenterology and hepatology, 48(4), 508-514.
  • Scott, R., McPhillips, M., Meldrum, C., FitzGerald, P., Adams, K., Spigelman, A., du Sart, D., Tucker, K., Kirk, J. (2001). Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. American Journal of Human Genetics, 68(1), 118-127.
  • Randall, J., Butow, P., Kirk, J., Tucker, K. (2001). Psychological impact of genetic counselling and testing in women previously diagnosed with breast cancer. Internal Medicine Journal, 31(7), 397-405.

2000

  • Meiser, B., Butow, P., Barratt, A., Friedlander, M., Kirk, J., Gaff, C., Haan, E., Aittomaki, K., Tucker, K. (2000). Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. Breast Cancer Research and Treatment, 59(2), 101-111.
  • Kirk, J., Kefford, R. (2000). Cancer in the family: risks and management. Medical Journal of Australia, 172(11), 529-530.
  • Meiser, B., Butow, P., Friedlander, M., Schnieden, V., Gattas, M., Kirk, J., Suthers, G., Haan, E., Tucker, K. (2000). Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. Journal of Clinical Oncology, 18(11), 2250-2257.
  • Osborne, R., Hopper, J., Kirk, J., Chenevix-Trench, G., Thorne, H., Sambrook, J. (2000). kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Medical Journal of Australia, 172(9), 463-464.

To update your profile click here. For support on your academic profile contact .